Technical Analysis for AERI - Aerie Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 42.15 -1.56% -0.67
AERI closed down 1.56 percent on Wednesday, January 16, 2019, on 89 percent of normal volume. It was able to find support at its 50 day moving average. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical AERI trend table...

Date Alert Name Type % Chg
Jan 16 50 DMA Support Bullish 0.00%
Jan 16 Outside Day Range Expansion 0.00%
Jan 16 Wide Bands Range Expansion 0.00%
Jan 16 Overbought Stochastic Strength 0.00%
Jan 15 NR7 Range Contraction -1.56%
Jan 15 Wide Bands Range Expansion -1.56%
Jan 15 Overbought Stochastic Strength -1.56%
Jan 14 MACD Bullish Centerline Cross Bullish -0.35%
Jan 14 Upper Bollinger Band Walk Strength -0.35%
Jan 14 Wide Bands Range Expansion -0.35%

Older signals for AERI ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Its product candidates include dual-action AR-13324, a once-daily eye drop to reduce intraocular pressure (IOP) in patients with glaucoma or ocular hypertension, which has completed a Phase IIb clinical trials; triple-action PG324, a single drop fixed-dose combination of AR-13324 and latanoprost for the treatment of patients with glaucoma; and AR-13533, a dual-action ROCK/NET inhibitor that is in preclinical development stage. The company was founded in 2005 and is headquartered in Bedminster, New Jersey.
Is AERI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 74.75
52 Week Low 32.18
Average Volume 608,894
200-Day Moving Average 54.8871
50-Day Moving Average 41.065
20-Day Moving Average 37.8125
10-Day Moving Average 40.63
Average True Range 2.141
ADX 27.92
+DI 24.4362
-DI 19.2112
Chandelier Exit (Long, 3 ATRs ) 37.127
Chandelier Exit (Short, 3 ATRs ) 38.603
Upper Bollinger Band 44.3375
Lower Bollinger Band 31.2875
Percent B (%b) 0.83
BandWidth 34.512397
MACD Line 0.5237
MACD Signal Line -0.4769
MACD Histogram 1.0006
Fundamentals Value
Market Cap 1.53 Billion
Num Shares 36.3 Million
EPS -3.26
Price-to-Earnings (P/E) Ratio -12.93
Price-to-Sales 0.00
Price-to-Book 12.18
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 46.22
Resistance 3 (R3) 46.23 44.89 45.54
Resistance 2 (R2) 44.89 43.85 44.88 45.31
Resistance 1 (R1) 43.52 43.22 42.85 43.51 45.09
Pivot Point 42.18 42.18 41.85 42.17 42.18
Support 1 (S1) 40.81 41.14 40.14 40.80 39.21
Support 2 (S2) 39.47 40.51 39.46 38.99
Support 3 (S3) 38.10 39.47 38.76
Support 4 (S4) 38.09